1) Salmeterol and fluticasone propionate powder
沙美特罗替卡松粉剂
1.
Results:Salmeterol and fluticasone propionate powder marked improvement in asthma symptoms.
目的:观察沙美特罗替卡松粉剂吸入后对支气管哮喘的治疗效果、安全性。
3) salmeterol-fluticasone
沙美特罗-替卡松粉
1.
Objective To evaluate the clinical effect of inhaling salmeterol-fluticasone on patients with COPD.
目的探讨吸入沙美特罗-替卡松粉治疗慢性阻塞性肺疾病(COPD)的疗效。
4) Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
沙美特罗氟替卡松粉吸入剂
1.
Nursing Intervention on Using Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation in COPD Patients;
慢性阻塞性肺疾病患者使用沙美特罗氟替卡松粉吸入剂的护理干预
5) salmeterol-fluticasone propionate dry powder for inhalation
沙美特罗-丙酸氟替卡松干粉吸入剂
1.
Fungal esophagitis caused by salmeterol-fluticasone propionate dry powder for inhalation
沙美特罗-丙酸氟替卡松干粉吸入剂导致霉菌性食管炎
6) Salmeterol/fluticasone propionate
沙美特罗替卡松
1.
Lung function and safety of children with moderate-severe asthma treated by salmeterol/fluticasone propionate;
沙美特罗替卡松治疗儿童中重度哮喘的肺功能及安全性观察
补充资料：沙美特罗
分子式：C25H37NO3
分子量：暂无
CAS号：89365-50-4
性质：暂无
制备方法：暂无
用途：支气管扩张药。
分子量：暂无
CAS号：89365-50-4
性质：暂无
制备方法：暂无
用途：支气管扩张药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条